Tranexamic Acid in Surgery of Advanced Ovarian Cancer

NCT00740116 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Tranexamic acid
DRUG: 0.9% NaCl solution

Sponsor

Preben Kjolhede, MD, professor